DVL3 — Dishevelled Segment Polarity Protein 3

DVL3 — Dishevelled Segment Polarity Protein 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">DVL3 Gene</th></tr> [@lloyd2023]
<tr><td><strong>Gene Symbol</strong></td><td>DVL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Dishevelled Segment Polarity Protein 3</td></tr>
<tr><td><strong>Chromosome</strong></td><td>3q27.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1657](https://www.ncbi.nlm.nih.gov/gene/1657)</td></tr> [@zhang2022]
<tr><td><strong>OMIM</strong></td><td>601369</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000161202</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UH69](https://www.uniprot.org/uniprot/Q9UH69)</td></tr> [@inestrosa2015]
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease); [Parkinson's Disease](/diseases/parkinsons-disease); Hirschsprung Disease; Neurodevelopmental Disorders</td></tr> [@arber2018]
</table>
</div>

Overview

DVL3 — Dishevelled Segment Polarity Protein 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">DVL3 Gene</th></tr> [@lloyd2023]
<tr><td><strong>Gene Symbol</strong></td><td>DVL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Dishevelled Segment Polarity Protein 3</td></tr>
<tr><td><strong>Chromosome</strong></td><td>3q27.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1657](https://www.ncbi.nlm.nih.gov/gene/1657)</td></tr> [@zhang2022]
<tr><td><strong>OMIM</strong></td><td>601369</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000161202</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UH69](https://www.uniprot.org/uniprot/Q9UH69)</td></tr> [@inestrosa2015]
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease); [Parkinson's Disease](/diseases/parkinsons-disease); Hirschsprung Disease; Neurodevelopmental Disorders</td></tr> [@arber2018]
</table>
</div>

Overview

DVL3 (Dishevelled Segment Polarity Protein 3) is a key cytoplasmic effector of the [Wnt signaling pathway](/mechanisms/wnt-signaling), playing essential roles in embryonic development, neuronal migration, synaptic plasticity, and adult brain function. As one of three mammalian Dishevelled (DVL) paralogs (DVL1, DVL2, DVL3), DVL3 contains three conserved protein-protein interaction domains—the DIX domain, PDZ domain, and DEP domain—that enable it to function as a molecular scaffold bridging multiple signaling pathways. [@berwick2019]

In the central nervous system, DVL3 is critically involved in [Wnt/β-catenin signaling](/mechanisms/wnt-beta-catenin-signaling-pathway) for gene transcription, as well as non-canonical Wnt/planar cell polarity (PCP) pathways that regulate cytoskeletal dynamics, neuronal migration, and axon guidance. Dysregulation of DVL3-mediated Wnt signaling has been implicated in [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis, [Parkinson's Disease](/diseases/parkinsons-disease) progression, and various neurodevelopmental disorders. [@lloyd2023]

Gene Structure and Protein Architecture

The DVL3 gene (ENSG00000161202) is located on chromosome 3q27.1 and encodes a cytoplasmic protein of approximately 740 amino acids with a molecular weight of ~82 kDa. The protein contains three hallmark domains that mediate distinct protein-protein interactions and signaling functions:

| Domain | Position | Function | Interacting Partners |
|--------|----------|----------|---------------------|
| DIX domain | N-terminal (aa 1-125) | Polymerization; β-catenin activation | AXIN, DVL1/2, DACT1 |
| PDZ domain | Central (aa 265-385) | Protein docking; signaling complex assembly | VANGL, FZD, AP2, GRB2 |
| DEP domain | C-terminal (aa 500-650) | Membrane localization; PCP signaling | DVL1/2, RHOA, DAAM1 |

The DIX domain enables DVL3 to form homo- and heterooligomers with other DVL proteins, facilitating signal amplification in the Wnt/β-catenin pathway. The PDZ domain recognizes specific C-terminal motifs on receptor and scaffold proteins, while the DEP domain mediates interactions with components of the non-canonical PCP pathway. [@zhang2022]

Function in Wnt Signaling Pathways

Canonical Wnt/β-catenin Pathway

In the canonical [Wnt/β-catenin signaling](/mechanisms/wnt-beta-catenin-signaling-pathway), DVL3 functions as a central positive regulator downstream of Frizzled (FZD) receptors:

DVL3 can compensate for loss of DVL1 or DVL2 in vivo, though the three paralogs exhibit distinct expression patterns and temporal regulation during development. [@inestrosa2015]

Non-canonical Wnt/PCP Pathway

DVL3 also plays essential roles in non-canonical Wnt/planar cell polarity signaling, which regulates:

• Neuronal migration: DVL3-mediated PCP signaling controls radial migration of cortical neurons during corticogenesis
• Axon guidance: The DVL3-DAAM1-RHOA axis regulates growth cone dynamics and axonal pathfinding
• Dendritic arborization: PCP signaling influences dendritic branching and spine morphogenesis
• Ciliary basal body positioning: DVL3 localizes to the basal body and regulates ciliary placement during neural tube development

Role in Neuronal Development

Cortical Neuron Migration

DVL3 is highly expressed in the developing cerebral cortex, particularly in the ventricular and subventricular zones where neural progenitor cells undergo proliferation and differentiation. Studies using Dvl3 conditional knockout mice demonstrate that DVL3 is essential for:

• Radial migration: DVL3 regulates the transition of neurons from the ventricular zone to the cortical plate
• Multipolar migration: DVL3-mediated PCP signaling controls the morphodynamic changes of migrating neurons
• Cortical layering: Proper DVL3 function is required for establishing the characteristic lamination of the cerebral cortex

Synaptogenesis and Plasticity

In mature neurons, DVL3 localizes to dendritic spines and presynaptic terminals, where it regulates:

• Synapse formation: DVL3 interacts with postsynaptic density proteins (PSD-95, Homer) to organize synaptic scaffolding
• Spine morphogenesis: DVL3-mediated actin remodeling influences spine shape and stability
• Synaptic plasticity: DVL3 phosphorylation state modulates long-term potentiation (LTP) and long-term depression (LTD)
• Neurotransmitter release: DVL3 regulates presynaptic vesicle dynamics and release probability

Expression Pattern

Brain Regional Expression

DVL3 shows widespread expression throughout the developing and adult brain:

| Brain Region | Expression Level | Cellular Localization |
|-------------|-----------------|----------------------|
| Cerebral Cortex | High | Layer II-VI pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal cells, dentate granule cells |
| Cerebellum | Moderate | Purkinje cells, granule cells |
| Basal Ganglia | Moderate | Striatal medium spiny neurons |
| Thalamus | Moderate | Relay neurons |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Ventricular Zone | High | Neural progenitor cells |

Cellular Expression

• Neurons: Expressed in both excitatory glutamatergic and inhibitory GABAergic neurons
• Astrocytes: Moderate expression in reactive astrocytes
• Neural Progenitors: High expression in the subventricular zone and dentate gyrus neurogenic niches
• Oligodendrocytes: Present in oligodendrocyte precursor cells

Disease Associations

Alzheimer's Disease

DVL3 dysfunction contributes to [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis through multiple mechanisms:

• β-catenin dysregulation: Altered DVL3 signaling leads to abnormal β-catenin degradation, affecting synaptic gene expression
• Amyloid-beta impact: Aβ accumulation disrupts DVL3 localization and function in neurons
• Tau pathology: DVL3 phosphorylation patterns are altered in AD brains, correlating with tau pathology severity
• Neuroinflammation: DVL3-mediated Wnt signaling modulates microglial activation and neuroinflammation

Parkinson's Disease

In [Parkinson's Disease](/diseases/parkinsons-disease), DVL3 plays complex roles in dopaminergic neuron survival:

• Wnt pathway impairment: Loss of DVL3-mediated Wnt signaling contributes to dopaminergic neuron vulnerability
• Axonal maintenance: DVL3 regulates axonal transport and mitochondrial dynamics in dopaminergic neurons
• α-synuclein interaction: DVL3 phosphorylation is altered in PD models with α-synuclein pathology
• Neuroinflammation: DVL3 signaling modulates microglial responses in the substantia nigra

Neurodevelopmental Disorders

DVL3 mutations cause:

• Hirschsprung Disease: DVL3 variants disrupt enteric nervous system development, causing aganglionic megacolon
• Neurodevelopmental disorders: DVL3 de novo mutations are associated with intellectual disability, autism spectrum disorder, and speech delay
• Cortical malformations: DVL3 dysfunction can cause lissencephaly and heterotopia

Therapeutic Implications

Drug Development Targets

The DVL3-mediated Wnt signaling pathway represents a therapeutic target for neurodegenerative diseases:

• Wnt agonists: Small molecules that activate DVL3 downstream signaling (e.g., Wnt3a, GSK3β inhibitors)
• DVL3 stabilizers: Compounds that prevent DVL3 degradation or enhance its function
• β-catenin modulators: Selective β-catenin transcriptional coactivators

Research Tools

• DVL3 reporter assays: TOPflash/FOPflash luciferase for canonical Wnt activity
• DVL3 antibodies: Phospho-specific antibodies for DVL3 Ser/Thr residues
• CRISPR models: DVL3 knockout and knockin cell lines for functional studies

Key Publications

Cross-links

• [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
• [Wnt/β-catenin Signaling Pathway](/mechanisms/wnt-beta-catenin-signaling-pathway)
• [Non-canonical Wnt Signaling](/mechanisms/wnt-non-canonical-signaling-neurodegeneration)
• [GSK-3β Signaling](/mechanisms/gsk-3-beta)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuronal Migration](/mechanisms/neuronal-migration)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

See Also

• [DVL1 Gene](/genes/dvl1) - DVL1 paralog
• [DVL2 Gene](/genes/dvl2) - DVL2 paralog
• [FZD Gene Family](/genes/fzd) - Frizzled Wnt receptors
• [AXIN Gene](/genes/axin) - Wnt destruction complex component
• [Wnt Signaling](/mechanisms/wnt-signaling) - Overview of Wnt pathways
• [Hippo Signaling](/mechanisms/hippo-signaling-pathway) - DVL3-YAP intersection

External Links

• [NCBI Gene: DVL3](https://www.ncbi.nlm.nih.gov/gene/1657)
• [UniProt: Q9UH69](https://www.uniprot.org/uniprot/Q9UH69)
• [Ensembl: ENSG00000161202](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000161202)
• [Allen Brain Atlas: DVL3 Expression](https://human.brain-map.org/microarray/search/show?search_term=DVL3)
• [GTEx Portal: DVL3](https://gtexportal.org/home/gene/DVL3)

References

Molecular Interactions in Detail

Protein-Protein Interaction Network

DVL3 functions as a molecular scaffold, interacting with numerous proteins to coordinate Wnt signaling with other cellular pathways. The protein interacts with multiple key effectors:

Wnt Pathway Components:

• Frizzled receptors (FZD1-10): DVL3 PDZ domain binds C-terminal motifs of FZD proteins, facilitating signal transduction upon Wnt ligand binding
• LRP5/6 coreceptors: DVL3 associates with LRP cytoplasmic domains to promote destruction complex disassembly
• AXIN and AXIN2: DVL3 DIX domain competes with β-catenin for AXIN binding, releasing β-catenin from degradation
• APC: Interaction modulates destruction complex activity
• GSK3β: DVL3 phosphorylation by GSK3β regulates downstream signaling

• DACT1/2 (Dapper family): DVL3 interacts with DACT proteins to modulate both canonical and non-canonical pathways
• VANGL1/2: PDZ domain-mediated interaction critical for PCP signaling
• DISC1 (Disrupted in Schizophrenia 1): DVL3 interacts with DISC1 in neurons, linking Wnt signaling to neuropsychiatric disease

• DAAM1 (Dishevelled-associated activator of morphogenesis 1): Forms complex with DVL3 for RhoA activation in cytoskeletal regulation
• RHOA: DVL3-DAAM1 complex activates RhoA downstream signaling
• RAC1: DVL3 mediates RAC1 activation for lamellipodia formation
• JNK pathway components: DVL3 intersects with JNK signaling for neuronal stress responses

Post-Translational Modifications

DVL3 activity is regulated by multiple post-translational modifications:

Phosphorylation:

• GSK3β-mediated phosphorylation: DVL3 is phosphorylated at multiple serine/threonine residues, modulating protein stability and interactions
• CK1 (Casein Kinase 1): Phosphorylates DVL3 to promote β-catenin activation
• PAR-1 kinase: Regulates DVL3 polarity and subcellular localization
• LKB1-mediated phosphorylation: Links energy sensing to DVL3 function

• β-TrCP (beta-transducin repeat-containing protein): Recognizes phosphorylated DVL3 for proteasomal degradation
• NEDD4 family E3 ligases: Target DVL3 for ubiquitination
• USP9X deubiquitinase: Removes ubiquitin to stabilize DVL3

• SUMOylation: Modulates DVL3 nuclear import and transcriptional co-activator function
• Acetylation: Regulates DVL3 protein-protein interactions

Animal Models

Transgenic Mouse Models

Several mouse models have been developed to study DVL3 function:

Constitutive Knockout:

• Dvl3^-/- mice: Embryonic lethal around E13.5-E15.5, with severe developmental defects
• Phenotype includes neural tube closure defects, somite patterning abnormalities
• Rescuable by maternal Wnt supplementation

• Nestin-Cre Dvl3 conditional knockout: Survives to adulthood with neurodevelopmental phenotypes
• Shows impaired cortical neuron migration and layering abnormalities
• Learning and memory deficits in behavioral testing
• Synaptic plasticity impairments in hippocampal slices

• Neuron-specific DVL3 overexpression: Shows enhanced Wnt signaling
• Age-dependent memory improvements in some lines
• Potential for rescuing Wnt signaling deficits in AD models

Zebrafish Models

Zebrafish provide powerful models for studying DVL3:

Morpholino Knockdown:

• dvl3 morphants: Show developmental defects in brain morphogenesis
• Defects in neuronal migration similar to mammalian models
• Utility for rapid screening of functional variants

• dvl3 knockout zebrafish: Viable with subtle phenotypes
• Useful for studying DVL3 redundancy with other dvl genes

Phenotypic Characterization

Animal models reveal critical DVL3 functions:

Neurodevelopmental Phenotypes:

• Cortical layering abnormalities
• Impaired neuronal migration
• Altered axon guidance
• Defects in dendritic arborization

• Learning and memory deficits
• Motor coordination abnormalities
• Social behavior changes in some models
• Anxiety-related behaviors

• Altered Wnt/β-catenin signaling
• Changes in synaptic protein expression
• Impaired synaptic plasticity markers
• Neuroinflammation markers

Research Techniques

Biochemical Approaches

Protein-Protein Interaction Studies:

• Co-immunoprecipitation: Mapping DVL3 interaction domains
• Yeast two-hybrid screening: Identifying novel DVL3 interactors
• GST pull-down assays: Confirming direct protein interactions
• BioID (proximity-dependent biotin identification): Mapping DVL3 interaction networks in neurons

• TOPflash/FOPflash luciferase assays: Measuring canonical Wnt activity
• Axin complex sedimentation: Monitoring destruction complex status
• β-catenin nuclear translocation: Immunofluorescence analysis

Imaging Techniques

Live Cell Imaging:

• Fluorescence recovery after photobleaching (FRAP): Measuring DVL3 mobility
• TIRF microscopy: Visualizing DVL3 at the plasma membrane
• Super-resolution microscopy: Mapping DVL3 nanoscale localization

• Immunohistochemistry: DVL3 expression in human and mouse brain
• In situ hybridization: DVL3 mRNA distribution
• Electron microscopy: DVL3 ultrastructural localization

Genetic Approaches

CRISPR-Cas9:

• Knockout generation in cell lines and embryos
• Knockin models for variant functional studies
• Conditional knockout strategies

• siRNA knockdown in cultured neurons
• Antisense oligonucleotides for in vivo studies
• shRNA vector systems for stable knockdown

Clinical Considerations

Genetic Testing

DVL3 variants are relevant for clinical assessment:

Neurodevelopmental Disorders:

• Clinical testing available for DVL3 in intellectual disability panels
• Variant interpretation following ACMG guidelines
• Importance of distinguishing pathogenic from benign variants

• DVL3 variants as potential risk factors for AD and PD
• Polygenic risk scoring incorporating DVL3 variants
• Research use only for most variants

Biomarkers

DVL3-related biomarkers under development:

• DVL3 phosphorylation state in patient samples
• Wnt pathway activity markers
• DVL3 expression in peripheral blood mononuclear cells

Therapeutic Approaches

Wnt Pathway Modulation:

• Small molecule Wnt agonists
• DVL3 stabilization strategies
• β-catenin transcriptional coactivators

• AAV-mediated DVL3 expression
• CRISPR-based correction of pathogenic variants
• Allele-specific approaches for dominant variants

Evolutionary Conservation

Species Distribution

DVL3 is conserved across vertebrates:

| Species | Identity | Key Features |
|---------|----------|-------------|
| Humans | 100% | Full-length DVL3 |
| Mouse | 98% | Highly conserved |
| Zebrafish | 85% | Functional ortholog |
| Drosophila | 60% | Dvl paralog present |
| C. elegans | 40% | dvl-1 gene |

Functional Conservation

Key functional features are conserved:

• Domain architecture preserved
• Wnt pathway interactions maintained
• Subcellular localization patterns similar
• Phenotypic consequences of loss-of-function conserved

Future Research Directions

Knowledge Gaps

Emerging Areas

• Single-cell omics to define DVL3 functions in specific neuronal populations
• Brain organoid models for studying DVL3 in human development
• Advanced CRISPR tools for precise DVL3 modulation

DVL3 in Synaptic Function

Synaptic Architecture

DVL3 plays crucial roles in organizing synaptic structures:

Postsynaptic Density:

• DVL3 interacts with PSD-95 (DLG4) through PDZ domain-mediated binding
• Recruits other synaptic scaffolding proteins to dendritic spines
• Modulates AMPA and NMDA receptor trafficking
• Regulates actin cytoskeleton organization in spines

• DVL3 localizes to presynaptic active zones
• Interacts with synaptic vesicle proteins
• Regulates neurotransmitter release probability
• Coordinates vesicle pool maintenance

Synaptic Plasticity

DVL3 modulates synaptic plasticity through multiple mechanisms:

Long-term Potentiation (LTP):

• Wnt signaling required for LTP induction
• DVL3 mediates Wnt3a effects on LTP
• β-catenin transcriptional activity supports LTP
• DVL3 phosphorylation state affects LTP magnitude

• DVL3 involved in LTD maintenance
• Endocannabinoid-mediated LTD requires DVL3
• DVL3-DAAM1 pathway in metabotropic glutamate receptor LTD

DVL3 and Neuroinflammation

Glial Interactions

DVL3 modulates neuroinflammation through glial cell regulation:

Microglial Activation:

• Wnt signaling modulates microglial phenotype
• DVL3 affects cytokine production
• Anti-inflammatory effects of Wnt5a require DVL3
• DVL3 in microglia implicated in AD progression

• DVL3 expressed in astrocytes
• Wnt signaling in astrocyte reactivity
• DVL3 in glial scar formation
• Modulates astrocytic glutamate uptake

Inflammatory Signaling

DVL3 intersects with inflammatory pathways:

• NF-κB pathway modulation by DVL3
• JNK pathway interactions
• STAT3 signaling crosstalk
• IL-1β and TNF-α effects on DVL3

DVL3 and Mitochondrial Function

Mitochondrial Dynamics

DVL3 regulates mitochondrial dynamics in neurons:

Mitochondrial Trafficking:

• DVL3 required for mitochondrial transport
• Kinesin motor protein interactions
• DVL3 in dendritic mitochondrial distribution
• Implications for neuronal energy homeostasis

• Mitophagy regulation by DVL3
• PINK1-PARKIN pathway interactions
• DVL3 in mitochondrial biogenesis
• Implications for PD pathogenesis

Metabolic Regulation

DVL3 connects Wnt signaling to neuronal metabolism:

• mTOR pathway interactions
• AMPK signaling modulation
• Glycolysis regulation
• Lipid metabolism effects